PureTech Health PLC (STU:0VQ)
€ 1.81 -0.03 (-1.63%) Market Cap: 451.44 Mil Enterprise Value: 8.59 Mil PE Ratio: 0 PB Ratio: 1.51 GF Score: 47/100

PureTech Health PLC at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 12, 2020 / 07:00PM GMT
Release Date Price: €2.62 (+1.16%)
Andrew E. Singer
Credit Suisse Group AG - MD of Healthcare Investment Banking Division

Okay. Hello, everyone. Good morning for those on the West Coast. Good afternoon for those in the East Coast. I'm Andy Singer with Credit Suisse. I'm very happy to introduce the team at PureTech Health. I'm joined by the executive management team led by Daphne Zohar, who is the Founder and CEO of PureTech Health; Bharatt, who is the President; and Eric Elenko, who's the Chief Innovation Officer.

This is a company I've known for a long time. They are leaders in innovation in biopharma. They've created a number of very innovative and leading founded companies across a range of therapeutic areas, a range of technologies. They've been very innovative financially and structurally. And they've got an exciting internal pipeline as well.

So with that as an introduction, I'm happy to turn it over to Daphne.

Daphne Zohar
PureTech Health plc - Founder, CEO & Executive Director

Thanks so much, Andy, and thanks to the Credit Suisse team for putting together this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot